Chapter 1 Genetic Contributions to the Pathogenesis of Alzheimer's Disease

Advances in Cell Aging and Gerontology

Volumn 3, Issue C, 1999, Pages 1-31

  Mattson, Mark P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956865373     PISSN: 15663124     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1566-3124(08)60021-8     Document Type: Article

References (151)

1. Ancolio K., Marambaud P., Dauch P., and Checler F. α-Secretase-derived product of β-amyloid precursor protein is decreased by presenilin-1 mutations linked to familial Alzheimer's disease. J. Neurochem. 69 (1997) 2494-2499
2. Bambrick L.L., Golovina V.A., Blaustein M.P., Yarowsky P.J., and Krueger B.K. Abnormal calcium homeostatis in astrocytes from the trisomy 16 mouse. Glia 19 (1997) 352-358
3. Barger S.W., and Mattson M.P. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40 (1996) 116-126
4. 2+ accumulation. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 9328-9332
5. Bartus R.T., Dean R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 214 (1982) 408-417
6. Benzi G., and Moretti A. Contributions of mitochondrial alterations to brain aging. Adv. Cell Aging Gerontol. (JAI Press, Greenwich, CT) 2 (1997) 129-160
7. Blacker, D., Wilcox, M.A., Laird, N.M., Rodes, L., Horvath, S.M., Go, R.C.P., Perry, R., Watson, B., Bassett, S.S., Mclnnis, M.G., Albert, M.S., Hyman, B.T. & Tanzi, R.E. (1998) Alpha-2 macro-globulin is a novel Alzheimer's disease gene on chromosome 12 Nat. Genet. In press.
8. q/11. J. Neurochem. 69 (1997) 570-580
9. Blanc E.M., Toborek M., Mark R.J., Hennig B., and Mattson M.P. Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurochem. 68 (1997) 1870-1881
10. Blanc E.M., Keller J.N., Fernandez S., and Mattson M.P. 4-Hydroxynonenal, a lipid peroxidation product, inhibits glutamate transport in astrocytes. Glia 22 (1998) 149-160
11. Borchelt D.R., Thinakaran G., Eckman C.B., Lee M.K., Davenport F., Ratovitsky T., Prada C.-M., Kim G., Seekins S., Yager D., Slunt H.H., Wang R., Seeger M., Levey A.I., Gandy S.E., Copeland N.G., Jenkins N.A., Price D.L., Younkin S.G., and Sisodia S.S. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17 (1996) 1005-1013
12. Boteva K., Vitek M., Mitsuda H., de Silva H., Xu P.T., Small G., and Gilbert J.R. Mutation analysis of presenillin 1 gene in Alzheimer's disease. Lancet 347 (1996) 130-131
13. Breitner J.C.S., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., and Anthony J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44 (1994) 227-232
14. Bruce-Keller A.J., Umberger G., McFall R., and Mattson M.P. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45 (1999) 8-15
15. Busciglio J., and Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378 (1995) 776-779
16. Busciglio J., Hartmann H., Lorenzo A., Wong C., Baumann K., Sommer B., Staufenbiel M., and Yankner B.A. Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J. Neurosci. 17 (1997) 5101-5107
17. Campion D., Flaman J.M., Brice A., Hannequin D., Dubois B., Martin C., Moreau V., Charbonnier F., Didierjean O., and Tardieu S. Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum. Mol. Genet. 4 (1995) 2373-2377
18. Campion D., Brice A., Dumanchin C., Puel M., Baulac M., De La Sayette V., Hannequin D., Duyckaerts C., Michon A., Martin C., Moreau V., Penet C., Martinez M., Clerget-Darpoux F., Agid Y., and Frebourg T. A novel presenilin 1 mutation resulting in familial Alzheimer's disease with an onset age of 29 years. Neuroreport 7 (1996) 1582-1584
19. Castano E., Prelli F., Wisniewski T., Golabek A., Kumar R., Soto C., and Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306 (1995) 599-604
20. Ceballos I., Nicole A., Briand P., Grimber G., Delacourte A., Flament S., Blouin J.L., Thevenin M., Kamoun P., and Sinet P.M. Expression of human Cu-Zn superoxide dismutase gene in transgenic mice: model for gene dosage effect in Down syndrome. Free Rad. Res. Commun (1991) 12-13 581-589
21. Conlon R.A., Reaume A.G., and Rossant J. Notchl is required for the coordinate segmentation of somites. Development 121 (1995) 1533-1545
22. Cook D.B., Sung J.C., Golde T.E., Felsenstein K.M., Wojczyk B.S., Tanzi R.E., Trojanowski J.Q., Lee V.M.Y., and Doms R.W. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9223-9228
23. Cribbs D.H., Chen L., Bendle S.M., and La Ferla F.M. Widespread neuronal expression of the presenilin-1 early-onset Alzheimer's disease in the murine brain. Am. J. Pathol. 148 (1996) 1797-1806
24. Cruts M., Backhovens H., Wang S.Y., Gassen G.V., Theuns J., De Jonghe C.D., Wehnert A., De Voecht J., De Winter G., and Cras P. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4 (1995) 2363-2371
25. Cutler N.R., Heston L.L., Davies P., Haxby J.V., and Schapiro M.B. NIH Conference. Alzheimer's disease and Down's syndrome: new insights. Ann. Intern. Med. 103 (1985) 566-578
26. Davis R.E., Miller S., Herrnstadt C., Ghosh S.S., Fahy E., Shinobu L.A., Galasko D., Thai L.J., Beal M.F., Howell N., and Parker Jr. W.D. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4526-4531
27. de la Torre J.C. Cerebrovascular changes in the aging brain. In: Mattson M.P., and Geddes J.W. (Eds). The Aging Brain 2 (1997), JAI Press, Greenwich, CT 77-107 Adv. Cell Aging Gerontol.
28. Doan A., Thinakaran G., Borchelt D.R., Slunt H.H., Ratovistsky T., Podlisny M., Selkoe D.J., Seeger M., Gandy S.E., Price D.L., and Sisodia S.S. Protein topology of presenilin 1. Neuron 17 (1996) 1023-1030
29. Doyle E., Bruce M.T., Breen K.C., Smith D.C., Anderton B., and Regan C.M. Intraventricular infusions of antibodies to amyloid β-protein precursor impair the acquisition of a passive avoidance response in the rat. Neurosci. Lett. 115 (1990) 97-102
30. Du Y., Bales K.R., Dodel R.C., Liu X., Glinn M.A., Horn J.W., Little S.P., and Paul S.M. α2-Macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70 (1998) 1182-1188
31. Duan W., and Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57 (1999) 195-206
32. Duff K., Eckman C., Zehr C., Yu X., Prada C.-M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., and Younkin S. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383 (1996) 710-713
33. Dyrks T., Dyrks E., Hartmann T., Masters C., and Beyreuther K. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267 (1992) 18210-18217
34. Elder G.A., Tezapsidis N., Carter J., Shioi J., Bouras C., Li D., Johnston J.M., Efthimiopoulos S., Friedrich V.L., and Robakis N.K. Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodent brains. J. Neurosci. Res. 45 (1996) 308-320
35. Evans K.C., Berger E.P., Cho C.G., Wiesbraber K.H., and Lansbury P.T. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 763-767
36. Finch C.E., and Morgan T.E. Food restriction and brain aging. In: Mattson M.P., and Geddes J.W. (Eds). The Aging Brain 2 (1997), JAI Press, Greenwich, CT 279-297 Adv. Cell Aging Gerontol.
37. Finch C.E., and Tanzi R.E. Genetics of aging. Science 278 (1997) 407-411
38. Furukawa K., and Mattson M.P. Secreted amyloid precursor protein a selectively suppresses NMDA receptor currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83 (1998) 429-438
39. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379 (1996) 74-78
40. Furukawa K., Sopher B., Rydel R.E., Begley J.G., Martin G.M., and Mattson M.P. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted APP is conferred by a C-terminal heparin-binding domain. J. Neurochem. 67 (1996) 1882-1896
41. Furukawa K., Guo Q., Schellenberg G.D., and Mattson M.P. Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52 (1998) 618-624
42. Gabuzda D., Busciglio J., Chen L., Matsudaira P., and Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269 (1994) 13623-13628
43. Giannakopoulos P., Bouras C., Kovari E., Shioi J., Tezapsidis N., Hof P.R., and Robakis N.K. Presenilin-1 immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am. J. Pathol. 150 (1997) 429-436
44. Goodman Y., and Mattson M.P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128 (1994) 1-12
45. Goodman Y., Bruce A.J., Cheng B., and Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66 (1996) 1836-1844
46. Green P.S., Gordon K., and Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 6 (1997) 229-235
47. Guo Q., Furukawa K., Sopher B.L., Pham D.G., Xie J., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. Neuroreport 8 (1996) 379-383
48. Guo G., Sopher B.L., Pham D.G., Furukawa K., Robinson N., Martin G.M., and Mattson M.P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17 (1997) 4212-4222
49. Guo Q., Christakos S., Robinson N., and Mattson M.P. Calbindin blocks the pro-apoptotic actions of mutant presenilin-1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3227-3232
50. Guo Q., Robinson N., and Mattson M.P. Secreted APPα counteracts the pro-apoptotic action of mutant presenilin-1 by activation of NF-κB and stabilization of calcium homeostasis J. Biol. Chem. 273 (1998) 12341-12351
51. Guo Q., Fu W., Xie J., Luo H., Sells S.F., Geddes J.W., Bondada V., Rangnekar V.M., and Mattson M.P. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nat. Med. 4 (1998) 957-962
52. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., and Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nature Med. 5 (1999) 101-106
53. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., and Mattson M.P. Increased vulnerability of hippocampal neurons from presenilin-1 mutant knock-in mice to amyloid beta-peptide toxicity: Central roles of superoxide production and caspase activation. J. Neurochem. 72 (1999) 1019-1029
54. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20 (1997) 154-159
55. Hartmann H., Busciglio J., Baumann K.H., Staufenbiel M., and Yankner B.A. Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J. Biol. Chem. 272 (1997) 14505-14508
56. Henderson V.W., Paganini-Hill A., Emanuel C.K., Dunn M.E., and Buckwalter J.G. Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51 (1994) 896-900
57. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R., and Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3270-3274
58. Hixon J.E. Apolipoprotein E polymorphisms affect atherosclerosis in young males. Arterioscler. Thromb. 11 (1991) 1237-1244
59. Hoyer S., Nitsch R., and Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J. Neural Transm. 3 (1991) 1-14
60. Huber G., Martin J.R., Loffler J., and Moreau J.L. Involvement of amyloid precursor protein in memory formation in the rat: an indirect antibody approach. Brain Res. 603 (1993) 348-352
61. Hutchin T.P., Heath P.R., Pearson R.C., and Sinclair A.J. Mitochondrial DNA mutations in Alzheimer's disease. Biochem. Biophys. Res. Commun. 241 (1997) 221-225
62. Ishida A., Furukawa K., Keller J.N., and Mattson M.P. Secreted form of β-amyloid precursor protein shifts the frequency dependence for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8 (1997) 2133-2137
63. Jagust W.J., Seab J.P., Huesman R.H., Valk P.E., Mathis C.A., Reed B.R., Coxson P.G., and Budinger T.F. Diminished glucose transport in Alzheimer's disease: dynamic PET studies. J. Cereb. Blood Flow Metab. 11 (1991) 323-330
64. Kamino K., Sato S., Sakaki Y., Yoshiiwa A., Nishiwaki Y., Takeda M., Tanabe H., Nishimura T., Ii K., George-Hyslop St.P.H., Miki T., and Ogihara T. Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families. Neurosci. Lett. 208 (1996) 195-198
65. +-ATPase activity, glucose transport and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50 (1997) 522-530
66. Keller J.N., Mark R.J., Bruce-Keller A.J., Blanc E.M., Rothstein J.D., Uchida K., and Mattson M.P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience 80 (1997) 685-696
67. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., and Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69 (1997) 273-284
68. Keller J.N., Guo Q., Holtsberg F.W., Bruce-Keller A.J., and Mattson M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18 (1998) 4439-4450
69. Keller J.N., Kindy M.S., Holtsberg F.W., Clair St.D.K., Yen H.C., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., and Mattson M.P. Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci. 18 (1998) 687-697
70. Kelly J., Furukawa K., Barger S.W., Mark R.J., Rengen M.R., Blanc E.M., Roth G.S., and Mattson M.P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 6753-6758
71. Kim T.-W., Pettingell W.H., Jung Y.-K., Kovacs D.M., and Tanzi R.E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277 (1997) 373-376
72. Kovacs D.M., Fausett H.J., Page K.J., Kim T.-W., Moir R.D., Merriam D.E., Hollister R.D., Hallmark O.G., Mancini R., Felsenstein K.M., Hyman B.T., Tanzi R.E., and Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nat. Med. 2 (1996) 224-229
73. Kruman I., Bruce-Keller A.J., Bredesen D.E., Waeg G., and Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17 (1997) 5097-5108
74. Lah J.J., Heilman C.J., Nash N.R., Rees H.D., Yi H., Counts S.E., and Levey A.I. Light and electron microscopic localization of presenilin-1 in primate brain. J. Neurosci. 17 (1997) 1971-1980
75. Lannfelt L., Basun H., Wahlund L.O., Rowe B.A., and Wagner S.L. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat. Med. 1 (1995) 829-832
76. Lassmann H. Patterns of synaptic and nerve cell pathology in Alzheimer's disease. Behav. Brain Res. 78 (1996) 9-14
77. Lehmann S., Chiesa R., and Harris D.A. Evidence for a six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272 (1997) 12047-12051
78. Levitan D., and Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377 (1995) 351-354
79. Levitan D., Doyle T.G., Brousseau D., Lee M.K., Thinakarin G., Slunt H.H., Sisodia S.S., and Greenwald I. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14940-14944
80. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.-E., Jondro P.D., Schmidt S.D., Wang K., Crowley A.C., Fu Y.-H., Guenette S.Y., Galas D., Nemens E., Wijsman E.M., Bird T.D., Schellenberg G.D., and Tanzi R.E. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269 (1995) 973-977
81. Loetscher H., Deuschle U., Brockhaus M., Reinhardt D., Nelboeck P., Mous J., Grunberg J., Haass C., and Jacobsen H. Presenilins are processed by caspase-type proteases. J. Biol. Chem. 272 (1997) 20655-20659
82. Loo D., Copani A., Pike C., Whittemore E., Walencewicz A., and Cotman C.W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7951-7955
83. 2+ homeostasis and cell death. J. Neurosci. 15 (1995) 6239-6249
84. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., and Mattson M.P. A role for 4-hydroxynonenal in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68 (1997) 255-264
85. Mark R.J., Pang Z., Geddes J.W., and Mattson M.P. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17 (1997) 1046-1054
86. Mattson M.P. Antigenic changes similar to those seen in neurofibrillary tangles are elicited by glutamate and calcium influx in cultured hippocampal neurons. Neuron 4 (1990) 105-117
87. Mattson M.P. Calcium as sculptor and destroyer of neural circuitry. Exp. Gerontol. 27 (1992) 29-49
88. Mattson M.P. Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J. Neurobiol. 25 (1994) 439-450
89. Mattson M.P. Untangling the pathophysiochemistry of β-amyloid. Nat. Struct. Biol. 2 (1995) 926-928
90. Mattson M.P. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77 (1997) 1081-1132
91. Mattson M.P. Mother's legacy: Mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci. 20 (1997) 373-375
92. Mattson M.P. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21 (1998) 53-57
93. Mattson M.P., and Begley J.G. Amyloid β-peptide alters thrombin-induced calcium responses in cultured human neural cells. Amyloid 3 (1996) 28-40
94. Mattson M.P., and Furukawa K. Programmed cell life: anti-apoptotic signaling and therapeutic strategies for neurodegenerative disorders. Retorative Neurol. Neurosci. 9 (1996) 191-205
95. Mattson M.P., and Rydel R.E. Amyloid ox-tox transducer. Nature 382 (1996) 674-675
96. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12 (1992) 376-389
97. Mattson M.P., Cheng B., Culwell A., Esch F., Lieberburg I., and Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10 (1993) 243-254
98. Mattson M.P., Fu W., Waeg G., and Uchida K. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport 8 (1997) 2275-2281
99. Mattson M.P., Goodman Y., Luo H., Fu W., and Furukawa K. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of MnSOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49 (1997) 681-697
100. Mattson M.P., Robinson N., and Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport 8 (1997) 3817-3821
101. Mattson M.P., Guo Q., Furukawa K., and Pedersen W.A. Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70 (1998) 1-14
102. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21 (1995) 195-218
103. Miyata M., and Smith J.D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14 (1996) 55-61
104. Montoya S.E., Aston C.E., DeKosky S.T., Kamboh M.I., Lazo J.S., and Ferrell R.E. Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat. Gen. 18 (1998) 211-212
105. Mucke L., Abraham C., Ruppe M., Rockenstein E., Togas S., Mallory M., Alford M., and Masliah E. Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein. J. Exp. Med. 181 (1995) 1551-1556
106. Mullan M., and Crawford F. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci. 16 (1993) 398-403
107. Murphy G.M., Forno L.S., Ellis W.G., Nochlin D., Levy-Lahad E., Poorkaj P., Bird T.D., Jiang Z., and Cordell B. Antibodies to presenilin proteins detect neurofibrillary tangles in Alzheimer's disease. Am. J. Pathol. 149 (1996) 1839-1846
108. Narita M., Holtzman D.M., Schwartz A.L., and Bu G. α2-Macroglobulin complexes with and mediates the endocytosis of β-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69 (1997) 1904-1911
109. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahle R.W., and Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264 (1994) 850-852
110. Nitsch M.R., Farber A.S., Growdon H.J., and Wurtman J.R. Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5191-5193
111. Pedersen W., Guo Q., Hartman B.K., and Mattson M.P. NGF-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1. J. Biol. Chem. 272 (1997) 22397-22400
112. Perez-Tur J., Froelich S., Prihar G., Crook R., Baker M., Duff K., Wragg M., Busfield F., Lendon C., Clark R.F., Roques P., Fuldner R.A., Johnston J., Cowburn R., Forsell C., Axelman K., Lilius L., Houlden H., Karran E., Roberts G.W., Rossor M., Adams M.D., Hardy J., Goate A., Lannfelt L., and Hutton M. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7 (1995) 297-301
113. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17 (1994) 525-530
114. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., and Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43 (1998) 815-825
115. Querfurth H.W., and Selkoe D.J. Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry 33 (1994) 4550-4561
116. Rebeck G.W., Reiter J.S., Strickland D.K., and Hyman B.T. Apolipoprotein in Alzheimer's disease: allelic variation and receptor interactions. Neuron 11 (1993) 575-580
117. Roch J.-M., Masliah E., Roch-Levecq A., Sundsmo M., Otero D.A., Veinbergs I., and Saitoh T. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7450-7454
118. Rogaev E.I., Sherrington R., Rogaeva E.A., Levesque G., Ikeda M., Liang Y., Chi H., Lin C., Holman K., Tsuda T., Mar L., Sorbi S., Nacmias B., Piacentini S., Amaducci L., Chumakov I., Cohen D., Lannfelt L., Fraser P.E., Rommens J.M., and George-Hyslop St.P.H. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376 (1995) 775-778
119. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., and Thai L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336 (1997) 1216-1222
120. Sapolsky R.M. The physiological relevance of glucocorticoid endangerment of the hippocampus. Ann. N.Y. Acad. Sci. 746 (1994) 294-304
121. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop St.P.H., Pericak V.M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., and Roses A.D. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
122. Schellenberg G.D., Kamino K., Bryant E.M., Moore D., and Bird T.D. Genetic heterogeneity, Down syndrome, and Alzheimer disease. Prog. Clin. Biol. Res. 379 (1992) 215-226
123. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., and Younkin S. The amyloid β protein deposited in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2 (1996) 864-870
124. Schupf N., Kapell D., Lee J.H., Ottman R., and Mayeux R. Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet 344 (1994) 353-356
125. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron 6 (1991) 487-498
126. Sells S.F., Han S.-S., Muthukkumar S., Maddiwar N., Johnstone R., Boghaert E., Gillis D., Liu G., Nair P., Monnig S., Collini P., Mattson M.P., Sukhatme V.P., Zimmer S.G., Wood D.P., McRoberts J.W., Shi Y., and Rangnekar V.M. Expression and function of the leucine zipper protein PAR-4 in apoptosis. Mol. Cell. Biol. 17 (1997) 3823-3832
127. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., and Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89 (1997) 629-639
128. Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L., Nee L., Chumakov I., Pollen D., Brookes A., Sansequ P., Polinsky R.J., Wasco W., Da Silva H.A.R., Haines J.L., Pericak-Vance M.A., Tanzi R.E., Roses A.D., Fraser P.E., Rommens J.M., and George-Hyslop St.P.H. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375 (1995) 754-760
129. Smale G., Nichols N.R., and Brady D.R. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133 (1995) 225-230
130. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., and Mattson M.P. Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63 (1994) 781-784
131. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
132. Sparks D.L., Scheff S.W., Hunziker J.C., Liu H., Landers T., and Gross D.R. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 126 (1994) 88-94
133. Su J.H., Anderson A.J., Cummings B., and Cotman C.W. Immunocytochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5 (1994) 2529-2533
134. Tanahashi H., Kawakatsu S., Kaneko M., Yamanaka H., Takahashi K., and Tabira T. Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients. Neurosci. Lett. 218 (1996) 139-141
135. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348 (1996) 429-432
136. Tang M.X., Stern Y., Marder K., Bell K., Gurland B., Lantigua R., Andrews H., Feng L., Tycko B., and Mayeux R. The Apo-E4 allele and risk of Alzheimer's disease among African Americans, whites and hispanics. JAMA. 279 (1998) 751-755
137. Uchihara T., el Hachimi H.K., Duyckaerts C., Foncin J.F., Fraser P.E., Levesque L., George-Hyslop St.P.H., and Hauw J.J. Widespread immunoreactivity of presenilin in neurons of normal and Alzheimer's disease brains: double-labeling immunohistochemical study. Acta Neuropathol. 92 (1996) 325-330
138. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., Neubauer A., Sonnemans M.A., Sluijs J.A., Koycu S., Ramdjielal R.D.J., Salehi A., Martens G.J.M., Grosveld F.G., Peter J., Burbach H., and Hoi E.M. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279 (1998) 242-247
139. Van Nostrand W.E., Wagner S.L., Shankle W.R., Farrow J.S., Dick M., Rozemuller J.M., Kuiper M.A., Wolters E.C., Zimmerman J., Cotman C.W., and Cunningham D. Decreased levels of soluble amyloid β-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2551-2555
140. Vito P., Ghayur T., and D'Adamio L. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage. J. Biol. Chem. 272 (1997) 28315-28320
141. Wallace D.C., Stugard C., Murdock D., Schurr T., and Brown M.D. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 14900-14905
142. Weidemann A., Paliga K., Durrwang U., Czech C., Evin G., Masters C.L., and Beyreufher K. Formation of stable complexes between two Alzheimer's disease gene products, presenilin-2 and β-amyloid precursor protein. Nat. Med. 3 (1997) 328-332
143. Whitson J., Mims M., Strittmatter W., Yamaki T., Morrisett J., and Appel S. Attenuation of the neurotoxic effect of Aβ amyloid peptide by apolipoprotein E. Biochem. Biophys. Res. Commun. 199 (1994) 163-170
144. Wise P.M., Herman J.P., and Landfield P. Neuroendocrine aspects of the aging brain. In: Mattson M.P., and Geddes J.W. (Eds). The Aging Brain 2 (1997), JAI Press, Greenwich, CT 193-241 Adv. Cell Aging Gerontol.
145. Wolozin B., Iwasaki K., Vito P., Ganjei J.K., Lacana E., Sunderland T., Zhao B., Kusiak J.W., Wasco W., and D'Adamio L. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274 (1996) 1710-1713
146. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J.S., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H.T., and Sisodia S.S. Presenilin 1 is required for Notch1 and Dll1 expression in the paraxial mesoderm. Nature 387 (1997) 288-292
147. Xia W., Zhang J., Perez R., Koo E.H., and Selkoe D.J. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 8208-8213
148. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
149. Yu Z.F., and Mattsoin M.P. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: Evidence for a preconditioning mechanism. J. Neurosci. Res. 57 (1999) 830-839
150. Zhang W., Han S.W., McKeel D.W., Goate A., and Wu J.Y. Interaction of presenilins with the filamin family of actin-binding proteins. J. Neurosci. 18 (1998) 914-922
151. Zhou J., Liyangage U., Medina M., Ho C., Simmons A.D., Lovett M., and Kosik K.S. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8 (1997) 1489-1494